Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.
Fiche publication
Date publication
avril 2016
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier, Mme POZET Astrid
Tous les auteurs :
Brieau B, Auzolle C, Pozet A, Tougeron D, Bouché O, Soibinet P, Coriat R, Prieux C, Lecomte T, Goujon G, Marthey L, Rougier P, Bonnetain F, Ducreux M, Taieb J, Zaanan A
Lien Pubmed
Résumé
Ovarian metastases from gastrointestinal tumours frequently lead to locoregional complications and undermine quality of life. The chemosensitivity of ovarian metastases from gastric cancer is unknown.
Mots clés
Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, therapeutic use, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Bridged-Ring Compounds, therapeutic use, Camptothecin, analogs & derivatives, Cisplatin, therapeutic use, Epirubicin, therapeutic use, Female, Fluorouracil, therapeutic use, France, Humans, Kaplan-Meier Estimate, Magnetic Resonance Imaging, Middle Aged, Multivariate Analysis, Ovarian Neoplasms, drug therapy, Ovariectomy, Prognosis, Proportional Hazards Models, Retrospective Studies, Stomach Neoplasms, drug therapy, Taxoids, therapeutic use, Tomography, X-Ray Computed, Treatment Outcome, Young Adult
Référence
Dig Liver Dis. 2016 Apr;48(4):441-5